OTTAWA — The Canadian Union of Postal Workers said in an official statement late Tuesday that it has given strike notice to Canada Post, a company that functions as the primary mail provider in Canada. If American postal workers are some of the kindest individuals in the public sector, I can only imagine the severity of whatever is causing the union to strike.
The Canadian Union of Postal Workers (CUPW) represents nearly 50,000 Canadian postal workers across the country. In their official press release, the union stated that if their demands are not met, “rotating strikes will begin at 12:01 am, Monday, October 22. Locations have yet to be determined. ”
As for their demands, the CUPW claims Canada Post needs to address issues of “health and safety, gender equality and preserving full-time, middle-class jobs,” says Mike Palecek, CUPW National President. The union has been reportedly pushing for 3.5% annual wage increases but has been met with offers far below inflation, Palecek added.
“Our goal is still negotiated settlements with no postal disruption. This week is Canada Post’s chance to make that happen-Mike Palecek, National President Canadian Union of Postal Workers
Canada Post spokesman Jon Hamilton, in response to union strike threats, said in a statement that the postal service has found common ground with the union before, with issues far more severe than this, and he confident a resolution will be found.
Hamilton also assured the Canadian public that the postal service will still be operational in the event of a strike, as Canada Post is the largest parcel service company in Canada.
The CUPW’s decision to advocate for their rights and strike, while important, comes at a very inconvenient time for many industries in Canada, notably the cannabis industry.
On Tuesday, at 12:01 am, distribution and use of recreational marijuana became legal for Canadian citizens, ending almost a century of prohibition. While many cannabis consumers are ecstatic about the news, individuals living in communities without retail cannabis shops have little to no access to the product.
It was at this moment, cannabis producers had a revelation. We can get more products to consumers if we offer delivery services through the Canada Post. Game changer.
According to the British Columbia Liquor Distribution Branch (BCLDB), the organization partnered with Canada Post to deliver cannabis. As far as the terms of the contract, customers will be responsible for a $10 shipping fee when ordering, and their orders will be shipped directly from the LDB’s warehouse within 48 hours of order submission. Ironically, or not, on the first official day that cannabis is recreational legal, the Canada Post decides to go on strike. Canada Post hasn’t officially stated that their demanded issue changes have any relation to cannabis distribution responsibilities.
While the Canada Post, the Postal Workers Union, and the BCLDB get their affairs in order, other companies in the space are implementing creative solutions to deliver the quality product to consumers.
Enter Choom (CHOOF), an “emerging adult use cannabis company” which has secured the rights to 52 retail opportunities across Western Canada, with 29 “highly strategic and sure locations” around the province.
Choom (CHOOF) has worked tirelessly to create their best-in-market retail storefront brand in the Canadian adult use market and officially announced in September, that they entered into a distribution agreement with ParcelPal Technology Inc. (“ParcelPal”) (PTNYF).
Step aside, Canada Post, and let the real cannabis players get their hands dirty. Gone are the days of standing for hours in line for your lunch, rushing to the store after work to grab your clothes, and now, waiting for Postal Workers Unions to settle their grievances.
ParcelPal (PTNYF), the pony express built for the digital age that Canadians have waited for, offers “on-demand delivery of merchandise from leading retailers, restaurants, liquor store and,” as of 12:01 am on Tuesday, medical and recreational marijuana.
“We recognize the importance of utilizing the existing technology of ParcelPal’s mobile app in concert with their outstanding track record of home delivery execution. We believe this will provide an exceptional customer experience and we are excited to offer this to our valued customers upon the upcoming rollout of our retail strategy.”
–Chris Bogart President and CEO Choom
As for the legality of cannabis delivery, ParcelPal (PTNYF), in partnership with Choom, will be held to the same standards as Canada Post. Upon delivering your product, you will need to show proper identification indicating that you are nineteen years or older.
I wish the Canadian Union of Postal Workers the best of luck in their organizing and hope that Canada Post takes their demands seriously. If either party starts to get stressed, no reason to panic. Choom (CHOOF) delivers.
Disclaimer: Pursuant to an agreement between MIDAM VENTURES, LLC an affiliate of JSG COMMUNICATIONS LLC, MIDAM VENTURES LLC. has been compensated $75,000 per month for 3 months by a ParcelPal Technology, Inc. for a period beginning September 1, 2018 and ending December 1, 2018 to publicly disseminate information about (PTNYF/PKG) to publicly disseminate information about (PTNYF/PKG). We may buy or sell additional shares of (PTNYF/PKG) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information. We own zero shares. Midam has been paid $80,000 from Choom Holdings and 200,000 restricted common shares of Choom Holdings for a duration of 4 months beginning May 14, 2018 and ending September 14, 2018. We may buy or sell additional shares of (CHOOF) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information. Click Here For Full Disclaimer
ParcelPal to distribute Yield’s cosmetics in Vancouver
ParcelPal Technology Inc. (PTNYF) (PKG.CN) has formed an alliance with Canadian cannabis topicals company, The Yield Growth Corp., for same-day and on-demand delivery, sale, of hemp-based cosmetics from Yield Growth’s subsidiary Urban Juve in Canada.
This initiative between Yield Growth and ParcelPal will commence in Vancouver as the catalyst city, and it is expected that additional cities will be rapidly added to this distribution network across Canada. Urban Juve’s customers will be able to purchase through Urban Juve’s website ( www.urbanjuve.com ) and ParcelPal will create an exclusive marketplace applications. Urban Juve hemp products are currently sold in over 90 locations including well known pharmacy chains across North America, with a plan to expand that to 130 retail outlets in the near future.
Customers will be able to track their purchase in real time and have their product delivered to any location they specify. As time and regulations allow, ParcelPal’s cannabis network will continue to grow, with the goal of capturing a major piece of Canada’s $5.2 B legal cannabis market.
President and CEO, Kelly Abbott states, “ParcelPal is thrilled to be working an innovative company such as The Yield Growth’s Corp, which is addressing one of the fastest-growing subsegments of the $4.2 trillion wellness market with unique derived and cannabis infused products. This marks a milestone at ParcelPal, launching a new vertical with substantial growth potential. It’s also a unique opportunity to be at the forefront of an exciting new industry with our unique logistics solutions.”
President and CEO of The Yield Growth Corp. Penny Green States “This new agreement is part of our continued efforts to serve our customers as seamlessly as possible,” says Penny Green, CEO of Yield Growth Corp. “ParcelPal is a great service, and our alliance will lay the groundwork for us to eventually offer same-day delivery service for pain management cannabis topicals and other cannabis products in jurisdictions where they’re legal.”
About The Yield Growth Corp.
The Yield Growth Corp. develops, manufactures and distributes cannabis and hemp infused luxury product brands Urban Juve and Wright & Well, and has a catalogue of over 200 wellness and beauty formulas. It intends to disrupt the international wellness market which is a 4.2 trillion global economy, according to the Global Wellness institute, by connecting ancient healing with modern science and technology. It’s management team has deep experience with global brands including Johnson & Johnson, Proctor and Gamble, M-A-C cosmetics, Sketchers, Best Buy Aritzia, Coca-Cola, and Pepsi Corporation. Yield Growth Serves mainstream luxury customers who seek sophisticated wellness products. It has flagship consumer brand, Urban Juve, has proprietary, patient pending hemp root extraction technology and has 12 patents pending. Yield Growth is building sophisticated international distribution channels and has multiple revenue streams including licensing, services and products.
About ParcelPal Technology Inc.
ParcelPal is a technology-driven logistics company that connects consumers to the goods they love. Customers can shop at partner businesses and through the ParcelPal technology receive their purchased goods within an hour.
The Company offers on-demand delivery of merchandise from leading retailers, restaurants, medical marijuana dispensaries and liquor stores in Vancouver and soon in major cities Canada-wide. ParcelPal Website: www.parcelpal.com
3 Cannabis Stocks In Focus This Week
One of the sectors that have enjoyed exponential growth over the past year or so is the marijuana sector and during the period, many of the stocks have gained significantly on the back of heightened investor interest.
It’s necessary to point out that in a fast-growing industry, it’s possible for stocks to rise significantly as well as the industry going through a fair bit of churn. Hence, investors could make significant returns if they manage to choose the right stock. Here is a look at 3 cannabis stocks.
Cannabis Stock To Watch #1: Driven Deliveries
Driven Deliveries (DRVD) focuses on several segments of the cannabis industry. Its leading service is for marijuana delivery in the United States. And this summer has been a busy time for Driven Deliveries. Most recently the company signed 10 brands as part of Driven’s Brand to Consumer cannabis delivery service.
In each of the partnerships, Driven has secured the rights to provide each brand with its own unique and branded e-commerce store with the transaction completed and fulfilled by Driven. Through the 10 branded e-commerce stores, and the Ganjarunner online store, Driven and its brand partners offer more than 500 retail items.
This includes edibles, topicals, elixirs, concentrates, smokable products, storage, apparel and accessories to customers in California. Because California is expected to reach over $4.7 billion in cannabis sales by 2025, the timing of this expansion could be opportune for the company.
Over the last few months, shares of Driven have traded in a range of $0.60 to $1.00 and are currently near the lower end of that range. Since the cannabis industry has started to see a resurgence of activity due to things like new ETF’s going live, the next move for the sector could be exciting to watch.
Cannabis Stock To Watch #2: CannTrust Holdings
CannTrust Holdings (TSX:TRST) (NYSE:CTST) is among the bigger producers of cannabis in the industry but the company had a setback on Monday after it emerged that one of its plants in Pelham had produced cannabis without a license from Health Canada. It happened in the months prior to the company getting its license in March.
5200 kilos of the production from the period is now going to be tested for compliance while 7500 kilos from another plant has been voluntarily held back by CannTrust. The shares fell by 22% on Monday but it should be noted that the company’s facilities are currently fully compliant with Health Canada regulations.
Cannabis Stock To Watch #3: OrganiGram Holdings
The other marijuana penny stock that gained last week due to an unexpected endorsement from one of the titans of the industry was OrganiGram Holdings (TSXV:OGI) (NASDAQ:OGI). The stock surged by as much as 8% after the former CEO and founder of industry leader Canopy Growth Brian Linton picked it as the one company with the potential for the biggest growth in the future.
Linton was voted out by the board of Canopy Growth but when asked about the company he likes, he stated that he had a good experience while dealing with OrganiGram in the past.
Premier Health and CB2 Insights Move to Second Phase of Primary Care Physician Tools for Medical Cannabis Evaluation
VANCOUVER, British Columbia, July 09, 2019 (GLOBE NEWSWIRE) — Premier Health Group (CSE: PHGI, OTCQB: PHGRF, Frankfurt: 6PH) (the “Company” or “Premier Health”), a Company focused on developing innovative approaches that combine human skill-based expertise with emerging technologies for the healthcare industry, has successfully completed Phase One of CB2 Insights’ (CSE:CBII) Clinical Decision Support (CDS) tool integration including targeted user testing.
Premier Health’s leading Electronic Medical Records (EMR) platform, Juno, will provide access to its over 4,600 primary care physician and healthcare practitioner users to the industry’s only data-driven platform that guides clinicians through the evaluation process for medical cannabis treatment. After a successful completion and user feedback within this first stage, both parties anticipate full rollout will be completed in Q3.
The agreement will be the first of its kind, with primary care physicians previously lacking the resources and tools required to assess the validity of medical cannabis as a treatment option for their patients. The CDS tool provides comprehensive guidelines for physicians to input patient-specific parameters into the system which is powered by proprietary algorithms leveraging data from more than 500 clinical research papers and trials as well as the anonymized and aggregate data of more than 450,000 patient encounters that CB2 Insights has managed through its clinical arm.
“At Premier Health, our mission is to integrate the best CDS tools directly into our Juno EMR platform that will equip physicians to make enhanced health-related decisions,” said Dr. Essam Hamza, CEO of Premier Health. “Our work with CB2 Insights has been long awaited by physicians who understand the benefits of medical cannabis, however are unsure of how to incorporate it within their clinics. We are excited to be bringing this robust and medically validated tool to our Juno userbase.”
“Physicians are the gatekeepers to any pharmacological treatment option for patients and enabling them to include medical cannabis into those options is a key advancement in the industry that all stakeholders should be excited about,” said Prad Sekar, CEO of CB2 Insights. “The success of this project thus far is confirmation that healthcare practitioners have been awaiting the tools that will help them remove the barriers that persist in the complicated world of medical cannabis. When you are dealing with a new treatment that can be applied to a wealth of patient indications from chronic pain to anxiety to sleep disorders and so on, paired with an array of medicine with varying levels of strength and outcome, we are proud to have created a tool that has received overwhelming physician support in this first stage.”
As part of Phase One, users were given the opportunity to test the system and provide feedback on both the applicability and user experience of the tool. The group of physicians who took part in Phase One included cannabis naïve physicians as well as those with advanced medical cannabis experience. Based on the positive feedback received from physicians, both parties agreed to immediately move into the final integration phase.
This agreement marks the first full-scale commercialization of CB2 Insights’ Data Insights business unit. CB2 Insights expects to monetize this tool through subscription of data reports paid for by Cannabis Licensed Producers from the aggregate and anonymized data collected on Canadian products. These reports will provide Producers with much needed clinically-generated efficacy data on specific products as well as the aggregate data to support research & development efforts and future commercialization. CB2 has already had successful conversations with Licensed Producers who have shown early commitment to subscribe to these reports.
As part of the agreement, CB2 will provide the development and continuous maintenance and support of the CDS tool and all related technologies. Premier Health will support the partnership by providing access to their software and will engage in education and training to its growing network of physicians and other healthcare professionals.
ON BEHALF OF THE BOARD OF DIRECTORS
“Dr. Essam Hamza, MD”
Chief Executive Officer
About Premier Health
Premier Health is a Canadian company that is strategically poised to take advantage of business opportunities in the global health care industry. We are focused on innovative health care approaches that combine human skill-based expertise with emerging technologies. Premier Health, in conjunction with its subsidiary Cloud Practice, a cloud-based SAAS Electronic Medical Records software company, is developing proprietary technology to deliver quality healthcare through the combination of connected primary care clinics with telemedicine and artificial intelligence (AI). We currently have a combined ecosystem of 290 clinics, over 3000 licensed practitioners and almost 3 million registered patients. The Premier Health team has deep clinical, operational and financial expertise and a passion for improving healthcare for all patients.
For more information on Juno EMR, please visit www.j unoemr. com.
About CB2 Insights
CB2 Insights has a mission to mainstream medical cannabis into traditional healthcare. We do so by gathering data and creating objective real-world evidence through our proprietary software and service brands. Using clinical management and data collection software at the point-of-care, CB2 Insights and its group of sub-brands has become a leading force behind bringing traditional healthcare protocols to the rapidly evolving global cannabis industry.
For more information please visit www.cb2insights.com.
The Canadian Securities Exchange does not accept responsibility for the adequacy or accuracy of this release.
FOR ADDITIONAL INFORMATION CONTACT:
Premier Health Group Inc.
Email: investors@ mypremierhealth .com
Renmark Financial Communications Inc.
Bettina Filippone: bfilippone @renmarkfinancial .com
Tel:(416) 644-2020 or (514) 939-3989
www. renmarkfinancial .com
Search Stock Price (StockPrice.com)
Sponsored Content1 month ago
Special Delivery! On-Demand Tech Companies Hit Billion-Dollar Valuations; Here’s How Investors Can Capitalize In The Market
Featured4 months ago
Multi-Trillion Dollar Industry Providing Massive Opportunity in 2019 & Beyond
Cannabis3 months ago
Two Massive Growth Industries, One Choice for Investors
Biotechnology1 month ago
Big Investments Are Signaling The Green Light For A ‘Hot Market’ With Cancer-Fighting Stocks
Featured1 month ago
This New Technology Could Transform A Multi-Billion-Dollar Industry!
Cannabis2 months ago
A New Cannabis Trend That The Market Should Take Immediate Notice Of Is Here!
Biotechnology2 weeks ago
The Future Of Drug Delivery Has Biotech Investors Focusing On One Small Company
Featured3 months ago
Opportunity Ahead for This Healthcare Stock